bezafibrate has been researched along with Angina Pectoris in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behar, S; Boyko, V; Fisman, EZ; Leor, J; Mandelzweig, L; Motro, M; Tenenbaum, A | 1 |
| Fukushima, H; Jinnouchi, H; Koga, H; Kugiyama, K; Ogawa, H; Sakamoto, T; Sugiyama, S; Watanabe, K; Yoshimura, M | 1 |
| Adler, Y; Behar, S; Benderly, M; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R | 1 |
| Barradell, LB; Goa, KL; Plosker, GL | 1 |
1 review(s) available for bezafibrate and Angina Pectoris
| Article | Year |
|---|---|
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction | 1996 |
3 other study(ies) available for bezafibrate and Angina Pectoris
| Article | Year |
|---|---|
Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis.
Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Bezafibrate; Cause of Death; Clinical Trials as Topic; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Follow-Up Studies; Heart Failure; Humans; Israel; Male; Mathematical Computing; Middle Aged; Myocardial Infarction; Patient Selection; Risk Factors | 2003 |
Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
Topics: Angina Pectoris; Bezafibrate; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Risk Factors | 2006 |
C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
Topics: Aged; Angina Pectoris; Bezafibrate; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Incidence; Israel; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment | 2006 |